| Alimentary Health Product Effective against Hospital-acquired Superbug C. Difficile |
|
Research published in the Proceedings of the National Academy of Sciences
more» |
| |
| Align wins Gold Medal at the Edison Best New Products Awards |
| |
| Novel Anti-Inflammatory Bifidobacterium animalis for Veterinary Purposes |
| |
| Exciting Anti C. difficile Peptide Presentation at DDW 2010 |
| |
| P&G Press Release - May 2009 |
| |
| IAMS Press Release, February 2009 |
Alimentary Health the Cork based development stage specialty biotechnology company, today announces that its licensing partner, P&G Pet Care, the maker of Iams Veterinary Formulas, has announced the launch of Prostora(TM) Max, a new probiotic supplement for dogs.
more» |
| |
| "One bacterium with solid science behind it is Bifidobacterium infantis 36524, the main ingredient in Procter & Gamble Company's Align dietary supplement." – Wall Street Journal (Jan 2009) |
| |
| Alimentary Health Ltd. Signs Exclusive Evaluation Agreement - November 2008 |
| |
| Alimentary Health Ltd. Announces Licensing Agreement with P&G Pet Care. |
Alimentary Health Expands the Use of Probiotics to Companion Animals.
more» |
| |
| New Study Shows Health Benefits of Probiotic Could Extend Beyond Gastrointestinal System |
Research Supports Strains' Ability to Limit Damage from Infection-related Inflammation
more» |
| |
| Experts Continue to Cite Bifantis® As Promising Probiotic Treatment for Irritable Bowel Syndrome |
|
Studies show inflammatory biomarkers return to normal levels, reduction in IBS symptoms after treatment with Bifantis
more» |
| |
| Alimentary Health makes six presentations at Digestive Diseases Week conference (DDW) 2008. |
|
Success of Alimentary Health underscores lead role being played by Irish companies in the treatment of gastrointestinal diseases.
more» |
| |
| Alimentary Health Enters into a Research and Development Agreement with General Mills Inc. |
Agreement to focus on the use of probiotics in food products
more» |
| |
| Alimentary Health - Publications Update |
| |
| Alimentary Health Ltd. receives orphan-drug designation for the treatment of pediatric ulcerative colitis |
|
Alimentary Health Ltd. (Alimentary Health),today announces that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA), has granted orphan-drug designation to Bifidobacterium infantis 35624 for the treatment of pediatric ulcerative colitis (UC).
more» |
| |
| Appointment to the Board May 2008 |
We are pleased to announce the appointment of Harry Cockrell to the Board in May.
more» |
| |
| Resignation from the Board April 2008 |
| |
| Alimentary Health Enters into Research and Development Agreement with ConvaTec |
|
Alimentary Health Ltd. (Alimentary Health), the
development stage specialty biotechnology company, announced today that it has entered
into an exclusive research and development agreement with ConvaTec, a world-leading
manufacturer of ostomy and wound care products.
more» |
| |
| Alimentary Health announces commencement of Clinical Study in Acute Diverticulitis |
|
Alimentary Health Ltd. (Alimentary Health), the development stage specialty biotechnology company, announces that the first patients have been recruited into a clinical study of Procter & Gamble Pharmaceuticals, Inc.'s (P&G) Asacol® (mesalamine) along with the supplemental Bifidobacterium infantis 35624, the Alimentary Health probiotic technology trademarked by P&G as Bifantis®, in the treatment of Acute Diverticulitis.
more» |
| |
| Alimentary Health's Probiotic Technology Increased Availability In Stores |
Alimentary Health Ltd. (Alimentary Health), a development stage specialty biotechnology company, welcomes the announcement by Procter & Gamble of the expanded distribution of its Align® product in three U.S. cities.
more» |
| |
| Alimentary Health Probiotic now available to U.S Pharmacists |
|
Alimentary Health Ltd's OTC product partner Procter & Gamble announced that ALIGN® is now available through wholesalers.
more» |
| |
| 2007 Operational Highlights |
Alimentary Health 2007 Operational Highlights
- Significantly strengthened relations with current partners
- New partner secured in an exciting area
- Strong research and development focus maintained
more» |
| |
| Recent Study Confirms Alimentary Health's Bifantis® Demonstrates Efficacy in the treatment of Irritable Bowel Syndrome |
| |
| We have moved – Alimentary Health announces that its Headquarters are now in the Cork Airport Business Park. |
| |
| Alimentary Health Announces Additional Clinical Studies Evaluation Agreement with Procter & Gamble |
|
Alimentary Health Ltd. (AH), a development stage specialty biotechnology company, announces that it has signed an agreement with Procter and Gamble (NYSE:PG) that will see AH probiotic technology receive further clinical evaluation in specific Gastrointestinal (GI) indications.
more» |
| |
| Alimentary Health Ltd, the Alimentary Pharmabiotic Centre (APC) foundation industry partner, welcomes the centre's progress with its research into C.Difficile Associated Diarrhoea (CDAD). |
|
Cork scientists research new treatment to combat bowel infection among the elderly.
more» |
| |
| Cork Ireland 1st September 2007 - Alimentary Health strengthens its management team and appoints Jack Allen BSc as Vice President – Operations. |
| |
| Dr. Declan Doogan MD joins AH as non-Executive Director |
| |
| Digestive Diseases Week® 2007 |
| |
| Probiotic Strain Bifantis(R) Anti-Inflammatory Properties |
| |
| 2006 Highlights |
| |
| Gastrointestinal Licensing Agreement with Procter & Gamble |
| |
| Alimentary Health Limited Secures €1.3 million in Funding |
| |
| AH announces agreement with Mead Johnson Nutritionals |
| |
